Home Applications 206947 Application 206947
Type NDA
Sponsor EISAI INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 LENVIMA LENVATINIB MESYLATE CAPSULE;ORAL EQ 4MG BASE Yes No 002 LENVIMA LENVATINIB MESYLATE CAPSULE;ORAL EQ 10MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N206947-001 LENVIMA LENVATINIB MESYLATE EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 N206947-002 LENVIMA LENVATINIB MESYLATE EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13
Orange Book patents# Current patent rows page 1 of 1 · 42 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 8 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 84e616aacf4f…2026-08-18 06:07:40 2026-07 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N206947-001 LENVIMA EQ 4MG BASE CAPSULE / ORAL RLD 2015-02-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N206947-002 LENVIMA EQ 10MG BASE CAPSULE / ORAL RLD, RS 2015-02-13 74a2ff9319b5…
Observed Orange Book patent history# Patent history page 1 of 23 · 884 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N206947-001 7253286 2025-10-24 Drug substance, Drug product 2015-03-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 7253286*PED 2026-04-24 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 7612208 2026-09-19 Drug substance, Drug product 2015-03-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 7612208*PED 2027-03-19 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 9006256 2027-07-27 U-1695 2015-05-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 9006256*PED 2028-01-27 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 12508313 2030-10-04 Drug product 2025-12-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 12508313*PED 2031-04-04 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 10259791 2035-08-26 Drug substance 2019-05-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 10407393 2035-08-26 Drug substance 2019-10-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 11186547 2035-08-26 Drug substance 2021-12-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 11090386 2036-02-23 U-3519 2023-02-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 10259791*PED 2036-02-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 10407393*PED 2036-02-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 11186547*PED 2036-02-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 12083112 2036-03-03 U-3996 2024-10-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 12083112 2036-03-03 U-3997 2024-10-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 11090386*PED 2036-08-23 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 12083112*PED 2036-09-03 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 12226409 2038-05-15 U-4146 2025-03-07 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-001 12226409*PED 2038-11-15 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 7253286 2025-10-24 Drug substance, Drug product 2015-03-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 7253286*PED 2026-04-24 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 7612208 2026-09-19 Drug substance, Drug product 2015-03-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 7612208*PED 2027-03-19 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 9006256 2027-07-27 U-1695 2015-05-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 9006256*PED 2028-01-27 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 12508313 2030-10-04 Drug product 2025-12-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 12508313*PED 2031-04-04 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 10259791 2035-08-26 Drug substance 2019-05-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 10407393 2035-08-26 Drug substance 2019-10-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 11186547 2035-08-26 Drug substance 2021-12-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 11090386 2036-02-23 U-3519 2023-02-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 10259791*PED 2036-02-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 10407393*PED 2036-02-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 11186547*PED 2036-02-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 12083112 2036-03-03 U-3996 2024-10-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 12083112 2036-03-03 U-3997 2024-10-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 11090386*PED 2036-08-23 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206947-002 12083112*PED 2036-09-03 Pediatric extension 84e616aacf4f…
Observed Orange Book exclusivity history# Exclusivity history page 4 of 12 · 442 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 2 · 136 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-704 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-708 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-710 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-712 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-714 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-714 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-714 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-714 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-714 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-714 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-714 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-714 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-714 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-714 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-714 Lenvima Lenvatinib Eisai Inc. NDA Current 62856-714 Lenvima Lenvatinib Eisai Inc. NDA Current